With a growing population of young patients with congenital heart disease reaching adulthood, this unique new book offers an in-depth guide to managing the challenges and issues related to device therapy in this patient group.
The only book resource dedicated to pacing, cardiac resynchronization therapy and ICD therapy for the pediatric and congenital heart disease patientï¿½
Contains practical advice for pacemaker and ICD implantation, programming, trouble-shooting, managing complications and follow upï¿½
Up-to-date with the latest in device technology
Contains multiple graphics, device electrogram tracings, and radiographic images for clarityï¿½
Includes video clips and over 150 multiple choice questions with extended answers on companion website, ideal for self test
An invaluable resource for both the specialist pediatric cardiologist and the general cardiologist responsible for children with heart disease and pacing devices
???Multimodality cardiovascular imaging is essential for interventional cardiac procedures and both fields are evolving rapidly. Multimodality Imaging in Cardiac Interventions captures the current state of clinical utility and provides a unique visual aide for teaching, training, and education. The editors have brought together a variety of leading experts from across the United Kingdom to guide the interested viewer in the indications and practicalities of state-of-the-art techniques. This book visually demonstrates the indications and methodology involved in several important cardiac interventions that rely heavily on multimodality cardiovascular imaging for their success. Chapters cover topics such as transcatheter aortic valve implantation (TAVI), device closure of paravalvular leaks in the mitral and aortic positions, and the adjunctive use of computed tomographic angiography in percutaneous coronary intervention. Visual simplicity in combination with excellent narration from experts in the field results in a unique up-to-date educational tool. This book will appeal to a wide range of professionals from clinicians to potential patients and the medical press interested in learning about important advances in cardiovascular medicine.
By (author): R. Eugene Zierler MD, Dr. David L Dawson M.D.
Now in its updated fifth edition, Strandness’s Duplex Scanning in Vascular Disorders proves why it’s still the classic text on the use of duplex scanning in the study and diagnosis of vascular disorders. This evidence-based, real-world text is now expanded to cover all vascular duplex ultrasound topics, including principles and instrumentation; cerebrovascular; aortoiliac and peripheral arterial; peripheral venous; visceral vascular; and preoperative planning, intraoperative assessment and procedural guidance.
NEW chapters on cardiovascular risk assessment, indirect physiologic assessment of lower extremity arteries, intravascular imaging and physiologic assessment, pelvic venous insufficiency, and vascular applications in point of care ultrasound
A practical, highly illustrative and easy to read reference for interventional cardiologists, vascular surgeons, cardiac/endovascular catheterization laboratory personnel, interventional radiologists, technical staff, industry professionals, investigators, and researchers on peripheral arterial CTO interventions.
Peripheral CTO lesions are present in nearly 50% of all peripheral arterial disease (PAD) endovascular interventions. There is tremendous growth in the performance and learning of peripheral arterial CTO procedures. There are several ongoing physician courses and many others that are being prepared; however, there is a significant lack of standardized selection, strategies, techniques and equipment necessary to achieve a high degree of reproducible success with low complication rates during the performance of these complex and technically challenging endovascular procedures.
The book is not an academic “tour de force” description of the topic but rather a practical one with many illustrations and step-by-step explanations of the various procedure steps, what can go wrong, and troubleshooting. Heavy use of illustrations throughout limit the text to what is necessary to convey the message, and the book is supported by online case catalogues and board review questions. The book also includes never-before-published information on new technology.
This is a concise review of up-to-date concepts and techniques in the discipline of heart transplantation. It is a review and reference for practitioners managing patients with advanced heart disease, including patients with end-stage heart failure, mechanical circulatory support or transplant recipients. Heart failure is a major public health issue, with a prevalence of over 5.8 million in the USA, and over 23 million worldwide, and rising. The lifetime risk of developing heart failure is one in five. Heart failure carries substantial morbidity and mortality, with 5-year mortality that rival those of many cancers. As heart transplantation remains the best treatment option for patients with end stage heart failure, this primer will provide valuable information and management strategies for physicians caring for these patients. Also, due to continued shortage in donor organs, heart transplantation is a limited resource – which further underscores the importance of appropriately evaluating patients for transplant candidacy and managing their pre, peri- and post-transplant care for maximum benefit and best outcomes.?
A concise, authoritative compilation of the essential knowledge needed to diagnose and manage cardiovascular disease
• 37 chapters cover the major disease entities and therapeutic challenges in cardiology today
• Chapters on major management issues such as pregnancy and heart disease, the use of anticoagulants in heart disease, and the perioperative evaluation of heart disease patients
• Each chapter written by experts in that area, without losing the readability or coherence found in single-author texts
• Logically organized into six sections: Prevention of Cardiovascular Disease, Ischemic Heart Disease, Arrhythmias, Valvular Disease, Cardiomyopathy and Heart Failure, and Systemic Disease and the Heart
• NEW MATERIAL on the latest hypertension guidelines, new therapies for dyslipidemia management, new oral anticoagulants, and new antiplatelet and antithrombotic drugs
• Organized for speed, ease of use, and clinical functionality
• An essential quick reference for experienced physicians in the clinic or on the ward, cardiology fellows, students and residents, nurses, technicians, and other health care staff who provide care for the cardiology patient
• More than 200 illustrations, including ECGs, imaging studies, drawings, graphs and charts
• Emphasis on must know information makes it perfect for board review
At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. But that’s changing, thanks to technological advances. Interventions in Structural, Valvular, and Congenital Heart Disease, Second Edition guides you throught the interventional treatment of congenital, valvular, and structural heart disease in the children and adults. The book emphasizes the practical aspects of procedures and covers other important areas such as indications and patient selection, potential pitfalls, and complications.
See What’s New in the Second Edition:
Contributions from new authors who are pioneers in structural interventions in adults and transcatheter aortic valve replacement
Expanded emphasis on the importance of imaging alongside the technical details of equipment and its safe and effective delivery
Coverage of emerging techniques at the forefront of interventional treatment such as fetal interventions, hybrid procedures, and mitral valve repair
Greater understanding, technical knowhow, and wider availability of catheters, balloons, delivery systems, and devices have spread intervention into the realm of acquired valve disease, degenerative disease of the aorta, paravalve leakage, postinfarction ventricular septal defects, and closure of the left atrial appendage. The book draws together expert interventionists from throughout the world to present approaches to congenital and structural heart disease that results in better outcomes for patients.
Congenital Heart Disease in Pediatric and Adult Patients: Anesthetic and Perioperative Management provides a comprehensive, up-to-date overview of care of the pediatric patient undergoing cardiac surgery and anesthesia. After introductory chapters that encompass pediatric cardiovascular embryology, physiology and pharmacology, diagnostic approaches and preoperative considerations are explained. The intraoperative management of a wide range of specific lesions is then discussed, with full descriptions of anesthesia plans added with descriptions on diagnostic methods and surgical interventions. Postoperative care is also addressed, and a concluding section considers anesthesia outside the cardiac operating room.
In the twenty-first century, advances in minimally invasive technology have led to the introduction of a wide array of pediatric cardiac procedures. More traditional surgical procedures have also been transformed by new devices and surgical approaches. The cardiac anesthesiologist is faced with an ever-increasing role in the perioperative care of pediatric patients undergoing cardiologic procedures in operating rooms, as well as less conventional locations. In this book, accomplished experts from around the world in the fields of pediatric anesthesia, cardiology, and cardiac surgery describe the multiple facets of caring for this very unique patient population.
This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.